Rajul Jain
InvestorManaging Director at Vida Ventures · Director at Capstan Therapeutics · Board director at Quanta Therapeutics
Santa Monica, California
Writes $100K – $10M checks · typically $1M
Find your path to Rajul
56 people in our graph share verified history with Rajul — schools, employers, funds. One of them is your warm intro.
About
Rajul Jain is a physician-scientist who led development and approval of CAR‑T therapies Yescarta and Tecartus, serves as a managing director taking active board roles, and speaks on advanced therapies.
Contact· published on Rajul's own website
Invests in
BiotechHealthtech
Director at Capstan Therapeutics
Intro paths
In turn, Rajul can intro founders to Capstan Therapeutics's investors below.
Capstan Therapeutics's investors · 4
Board director at Quanta Therapeutics
Intro paths
In turn, Rajul can intro founders to Quanta Therapeutics's investors below.
Experience
- Vida Ventures, LLCManaging Directorcurrent2019 — present
Investments
Board seats
Investor
AdcendoInduProInnoskelLB PharmaceuticalsLocanabioSonoThera
Sources: SEC Form D filings · curated public sources.
Colleagues at Vida Ventures
Network3
Investors connected to Rajul in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Rajul Jain?
- Rajul Jain is a physician-scientist who led development and approval of CAR‑T therapies Yescarta and Tecartus, serves as a managing director taking active board roles, and speaks on advanced therapies.
- Where does Rajul Jain work?
- Rajul Jain is Managing Director at Vida Ventures and Board director at Quanta Therapeutics.
- What does Rajul Jain invest in?
- Rajul Jain invests in Biotech, Healthtech.
- What check size does Rajul Jain write?
- Rajul Jain typically writes checks of $100K – $10M.
- What boards does Rajul Jain sit on?
- Rajul Jain holds tracked board seats at Neogene Therapeutics.
- What companies has Rajul Jain invested in?
- Investments tracked here include Adcendo, InduPro, Innoskel, LB Pharmaceuticals, Locanabio, SonoThera.